SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-18-356778
Filing Date
2018-12-24
Accepted
2018-12-21 21:10:34
Documents
2
Group Members
PIVOTAL BIOVENTURE PARTNER FUND I G.P., L.P.PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P., LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d677268dsc13d.htm SC 13D 77838
2 EXHIBIT 1 d677268dex991.htm EX-99.1 6461
  Complete submission text file 0001193125-18-356778.txt   86209
Mailing Address CODAN TRUST COMPANY (CAYMAN) LIMITED CRICKET SQ., HUTCHINS DR., GEORGE TOWN GRAND CAYMAN E9 KY1-1111
Business Address CODAN TRUST COMPANY (CAYMAN) LIMITED CRICKET SQ., HUTCHINS DR., GEORGE TOWN GRAND CAYMAN E9 KY1-1111 (345) 949 1040
Pivotal bioVenture Partners Fund I, L.P. (Filed by) CIK: 0001695076 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SC 13D

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Subject) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90651 | Film No.: 181251095
SIC: 2834 Pharmaceutical Preparations